MENU
+Compare
ELDN
Stock ticker: NASDAQ
AS OF
Jun 6 closing price
Price
$3.08
Change
+$0.10 (+3.36%)
Capitalization
178.15M

ELDN Eledon Pharmaceuticals Forecast, Technical & Fundamental Analysis

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company... Show more

ELDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ELDN with price predictions
May 28, 2025

Momentum Indicator for ELDN turns positive, indicating new upward trend

ELDN saw its Momentum Indicator move above the 0 level on May 23, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 91 similar instances where the indicator turned positive. In of the 91 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for ELDN just turned positive on May 20, 2025. Looking at past instances where ELDN's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .

ELDN moved above its 50-day moving average on May 28, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ELDN advanced for three days, in of 246 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The 50-day moving average for ELDN moved below the 200-day moving average on April 28, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ELDN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ELDN entered a downward trend on May 27, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.555) is normal, around the industry mean (16.080). P/E Ratio (4.808) is within average values for comparable stocks, (59.383). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.197). Dividend Yield (0.000) settles around the average of (0.039) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (268.270).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ELDN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ELDN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ELDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ELDN is expected to report earnings to rise 170.88% to -21 cents per share on August 07

Eledon Pharmaceuticals ELDN Stock Earnings Reports
Q2'25
Est.
$-0.22
Q1'25
Beat
by $0.17
Q4'24
Missed
by $0.32
Q3'24
Est.
$-0.32
Q2'24
Missed
by $0.09
The last earnings report on May 14 showed earnings per share of -7 cents, beating the estimate of -25 cents. With 190.48K shares outstanding, the current market capitalization sits at 178.15M.
A.I. Advisor
published General Information

General Information

a developer of pharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
19900 MacArthur Boulevard
Phone
+1 949 238-8090
Employees
20
Web
https://www.eledon.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

ELDN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ELDN has been loosely correlated with CDXS. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ELDN jumps, then CDXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELDN
1D Price
Change %
ELDN100%
N/A
CDXS - ELDN
38%
Loosely correlated
-8.63%
AMLX - ELDN
36%
Loosely correlated
+1.48%
ABSI - ELDN
36%
Loosely correlated
+0.74%
RVMD - ELDN
36%
Loosely correlated
+2.04%
DNLI - ELDN
36%
Loosely correlated
-1.29%
More